149_th Global

Antoni Torres

臨床医学

Clinical Medicine

Destaca también en

Immunology, Microbiology, Pharmacology & Toxicology

UNIV BARCELONA

Barcelona / España

149_th Global

Mentions data

Menciones por sus áreas de investigación

Clinical Medicine

Twitter
3.5K
Wikipedia
2
News
26
Policy
7

Immunology

Twitter
802
Wikipedia
2
News
48
Policy
3

Microbiology

Twitter
290
Wikipedia
3
News
24
Policy
1

Pharmacology & Toxicology

Twitter
198
Wikipedia
2
News
12
Policy
3

Mentions Chart

Influratio by dimension

Twitter
Wikipedia
News
Policy

PERSONA MENTIONS

Twitter
9.2K
Wikipedia
15
News
184
Policy
27

Trabajos con más influratio

Clinical Medicine

Todos sus trabajos en el área Clinical Medicine

Mentions 393 Twitter 0 Wikipedia 1 News 2 Policy

Article International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Torres, A; Niederman, MS; Chastre, J; Ewig, S; Fernandez-Vandellos, P; Hanberger, H; Kollef, M; Bassi, GL; Luna, CM; Martin-Loeches, I; Paiva, JA; Read, RC; Rigau, D; Timsit, JF; Welte, T; Wunderink, R EUROPEAN RESPIRATORY JOURNAL 0903-1936 (2017) DOI / 10.1183/13993003.00582-2017 OPEN ACCESS LEVEL / Bronze

Mentions 236 Twitter 0 Wikipedia 0 News 0 Policy

Editorial Material Biomarkers in the ICU: less is more? No Torres, A; Artigas, A; Ferrer, R INTENSIVE CARE MEDICINE 0342-4642 (2021) DOI / 10.1007/s00134-020-06271-4 OPEN ACCESS LEVEL / Green Published, Bronze

Immunology

Todos sus trabajos en el área Immunology

Mentions 68 Twitter 0 Wikipedia 17 News 0 Policy

Letter Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection Bermejo-Martin, JF; Almansa, R; Menendez, R; Mendez, R; Kelvin, DJ; Torres, A JOURNAL OF INFECTION 0163-4453 (2020) DOI / 10.1016/j.jinf.2020.02.029 OPEN ACCESS LEVEL / Green Published

Mentions 169 Twitter 0 Wikipedia 3 News 2 Policy

Article Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial Torres, A; Zhong, NS; Pachl, J; Timsit, JF; Kollef, M; Chen, ZJ; Song, J; Taylor, D; Laud, PJ; Stone, GG; Chow, JW LANCET INFECTIOUS DISEASES 1473-3099 (2018) DOI / 10.1016/s1473-3099(17)30747-8 OPEN ACCESS LEVEL / Green Accepted

Microbiology

Todos sus trabajos en el área Microbiology

Mentions 41 Twitter 1 Wikipedia 9 News 0 Policy

Article A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Path Huang, DB; O'Riordan, W; Overcash, JS; Heller, B; Amin, F; File, TM; Wilcox, MH; Torres, A; Dryden, M; Holland, TL; McLeroth, P; Shukla, R; Corey, GR CLINICAL INFECTIOUS DISEASES 1058-4838 (2018) DOI / 10.1093/cid/cix987 OPEN ACCESS LEVEL / Bronze, Green Published

Mentions 7 Twitter 0 Wikipedia 10 News 0 Policy

Article Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections Huang, DB; Corey, GR; Holland, TL; Lodise, T; O'Riordan, W; Wilcox, MH; File, TM; Dryden, M; Balser, B; Desplats, E; Torres, A INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 0924-8579 (2018) DOI / 10.1016/j.ijantimicag.2018.05.012 OPEN ACCESS LEVEL / NA

Pharmacology & Toxicology

Todos sus trabajos en el área Pharmacology & Toxicology

Mentions 7 Twitter 0 Wikipedia 10 News 0 Policy

Mentions 60 Twitter 0 Wikipedia 0 News 0 Policy

Review Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia Eljaaly, K; Botaish, A; Bahobail, F; Almehmadi, M; Assabban, Z; Thabit, AK; Alraddadi, B; Aljabri, A; Alqahtani, N; Aseeri, MA; Hashim, A; Torres, A JOURNAL OF CHEMOTHERAPY 1120-009X (2020) DOI / 10.1080/1120009x.2019.1680116 OPEN ACCESS LEVEL / NA

Among researchers in Clinical Medicine